Founded in 2006, SPDR S&P Biotech provides investors with opportunities and exposure to the Biotechnology industry. SPDR S&P Biotech is an equal-weighted index for over 100 stocks in all cap sizes. The fund is considered by some to have a small pharma overlap and not solely a biotech index. Some in the financial sector believe that SPDR S&P Biotech is ideal for traders who are looking to balance their portfolios with biotech equity allocation. The fund is located in Boston and is managed by State Street Global Advisors. |